Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF).

Autoria(s): Martin, Lorraine; Pasteur, M.; Keogan, M.; Elborn, Joseph; Buckingham, S.; Bilton, D.; Edgar, J.
Data(s)

01/03/1999
Identificador

http://pure.qub.ac.uk/portal/en/publications/safety-and-tolerability-of-four-ascending-single-doses-of-transgenic-sheep-derived-human-alpha1antitrypsin-tghaat-administered-by-a-nebuliser-to-patients-with-cystic-fibrosiscf(e447123b-8b94-4d05-a305-17e795eaa316).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Martin , L , Pasteur , M , Keogan , M , Elborn , J , Buckingham , S , Bilton , D & Edgar , J 1999 , ' Safety and tolerability of four ascending single doses of transgenic sheep derived human alpha-1-antitrypsin (tg-hAAT) administered by a nebuliser to patients with cystic fibrosis(CF). ' Paper presented at American Thoracic Society Conference , San Diego, CA , United States , 07/04/1999 - 10/04/1999 , pp. A191-A191 .
Tipo

conferenceObject
Acesso ao item digital